Latest Quinazolines Stories
A GRANDMOTHER with terminal cancer who faced moving to Scotland to get life-saving drugs free on the NHS has won her battle with health bosses in England to fund the medication that is keeping her alive.
By ; wire Shares of South San Francisco-based Genentech dropped nearly 8 percent after the company announced with OSI Pharmaceuticals that a combination of two cancer drugs, Avastin with Tarceva, missed its primary goal in a clinical trial, failing to improve survival for patients with late-stage lung cancer.
Blockbuster cancer drug Avastin has suffered a setback, failing to improve overall survival when added to Tarceva in a Phase III trial for second-line advanced non-small cell lung cancer.
Genentech and OSI Pharmaceuticals have announced that a randomized Phase III study evaluating Avastin in combination with Tarceva in patients with advanced non-small cell lung cancer whose disease had progressed following platinum-based chemotherapy did not meet its primary endpoint of improving overall survival compared to Tarceva in combination with placebo.
Genentech, Inc. (NYSE:DNA) and OSI Pharmaceuticals, Inc.
By Martin Eatock A new drug called Lapatinib was recently hailed a "big step forward" for women suffering from advanced breast cancer.
Chinese medical scientists say the drug gefitinib (Iressa) should be considered the first-line therapy for non-smoking Asian patients with lung cancer.
Cyclacel Pharmaceuticals, Inc.
The medical advisory panel to the UK National Health Service has recommended that GlaxoSmithKline's Tyverb should not be used on the NHS to treat advanced metastatic breast cancer on the grounds that it is not effective enough to justify its cost.
By Barry Nelson A FATHER-OF-THREE who was trying to raise [pounds]20,000 to buy a new cancer drug has died at home surrounded by family. Colin Glease, 45, from Dipton, near Stanley, County Durham, died on Saturday from advanced pancreatic cancer.